Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hilton Kaplan, Aslam Amod, Francois H van Zyl, Jeevren Reddy, Alet van Tonder, Ellina Tsymbal & Alicia McMaster. (2019) Incidence of hypoglycaemia in the South African population with diabetes: results from the IDMPS Wave 7 study. Journal of Endocrinology, Metabolism and Diabetes of South Africa 24:2, pages 58-64.
Read now
Read now
Jieruo Liu, Rosa Wang, Michael L. Ganz, Yurek Paprocki, Doron Schneider & James Weatherall. (2018) The burden of severe hypoglycemia in type 2 diabetes. Current Medical Research and Opinion 34:1, pages 179-186.
Read now
Read now
Jieruo Liu, Rosa Wang, Michael L. Ganz, Yurek Paprocki, Doron Schneider & James Weatherall. (2018) The burden of severe hypoglycemia in type 1 diabetes. Current Medical Research and Opinion 34:1, pages 171-177.
Read now
Read now
James Weatherall, Lisa Bloudek & Sarah Buchs. (2017) Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine. Current Medical Research and Opinion 33:2, pages 231-238.
Read now
Read now
Yingnan Zhao, Qian Shi, Yao Wang, Vivian Fonseca & Lizheng Shi. (2016) Economic burden of hypoglycemia: Utilization of emergency department and outpatient services in the United States (2005–2009). Journal of Medical Economics 19:9, pages 852-857.
Read now
Read now
Michał Jakubczyk, Elżbieta Rdzanek, Maciej Niewada & Marcin Czech. (2015) Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis. Expert Review of Pharmacoeconomics & Outcomes Research 15:5, pages 813-822.
Read now
Read now
Michael L. Ganz, Qian Li, Neil S. Wintfeld, Yuan-Chi Lee, Christopher Sorli & Joanna C. Huang. (2015) The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin. Current Medical Research and Opinion 31:9, pages 1809-1815.
Read now
Read now
Articles from other publishers (10)
Yaguang Zheng, Victoria Vaughan Dickson, Saul Blecker, Jason M Ng, Brynne Campbell Rice, Gail D’Eramo Melkus, Liat Shenkar, Marie Claire R Mortejo & Stephen B Johnson. (2022) Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review. JMIR Diabetes 7:2, pages e34681.
Crossref
Crossref
Jordan HinaharaStuart A WeinzimerEmilie R BromleyThomas F GossDavid M KendallMette Hammer. (2022) Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model. Journal of Managed Care & Specialty Pharmacy 28:4, pages 461-472.
Crossref
Crossref
I. Hodish. (2018) Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story. Clinical Diabetes and Endocrinology 4:1.
Crossref
Crossref
Carla Torre, José Pedro Guerreiro, Sónia Romano, Ana Miranda, Patrícia Longo, Sílvia Alão, João Conceição & Pedro Laires. (2018) Real-world prevalence of mild to moderate hypoglycemic episodes in type 2 diabetes in Portugal: Results from the HIPOS-PHARMA study. Primary Care Diabetes 12:6, pages 537-546.
Crossref
Crossref
Chris J. Alexiu, Anderson Chuck, Susan E. Jelinski & Brian H. Rowe. (2017) Presentations for hypoglycemia associated with diabetes mellitus to emergency departments in a Canadian province: A database and epidemiological analysis. Diabetes Research and Clinical Practice 130, pages 229-236.
Crossref
Crossref
Anthony P. Nunes, Jing Yang, Larry Radican, Samuel S. Engel, Karen Kurtyka, Kaan Tunceli, Shengsheng Yu, Kristy Iglay, Michael C. Doherty & David D. Dore. (2016) Assessing occurrence of hypoglycemia and its severity from electronic health records of patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 121, pages 192-203.
Crossref
Crossref
P. D. Home. (2015) Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?. Diabetes, Obesity and Metabolism 17:11, pages 1011-1020.
Crossref
Crossref
Xiaoyan Zhou, Fang Zhang, Xiaotong Hu, Jing Chen, Xiangru Wen, Ying Sun, Yonghai Liu, Renxian Tang, Kuiyang Zheng & Yuanjian Song. (2015) Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice. Physiology & Behavior 151, pages 412-420.
Crossref
Crossref
G. Schernthaner, J. Rosas-Guzmán, F. Dotta, B. Guerci, R. Simó, A. Festa, J. Kiljański, M. Zhou & B. Gallwitz. (2015) Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study. Diabetes, Obesity and Metabolism 17:7, pages 689-698.
Crossref
Crossref
Jinsong Geng, Hao Yu, Yiwei Mao, Peng Zhang & Yingyao Chen. (2015) Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes. PharmacoEconomics 33:6, pages 581-597.
Crossref
Crossref